Prevalence, Causes and Management of Encephalitis

Ibrahim Mahmoud H. Ajwah *

King Salman Military Hospital, Tabuk, Saudi Arabia.

Samirah Nawaf Naif Alrashidi

Majmaa University, Saudi Arabia.

Nouf Zayed Omer Al mutairi

Majmaa University, Saudi Arabia.

Ahmad Mazroa Almazroa

Majmaa University, Saudi Arabia.

Abdulrahman Jaser F. Almutairi

Majmaa University, Saudi Arabia.

Bushra Saad Alsakran

Majmaa University, Saudi Arabia.

Mujeb Mosfer Mujeb Alzhrani

Al Baha university, Saudi Arabia.

Maryam Jafar Alhashim

Imam Abdulrahman Bin Faisal University, Saudi Arabia.

Sara Mohammed Alsakran

Majmaa University, Saudi Arabia.

Wejdan Hani Alhakeem

Imam Abdulrahman Bin Faisal University, Saudi Arabia.

Abdulaziz Fahad Salamh

Prince Sattam Bin Abdulaziz University, Saudi Arabia.

Mubarak Ali M. Almanaah

Majmaa University, Saudi Arabia.

Wa’ad Massoud Almonser Alqahtani

Imam Mohammad Ibn Saud Islamic University (IMSIU), Saudi Arabia.

*Author to whom correspondence should be addressed.


Abstract

Encephalitis is a major cause of morbidity, mortality, and permanent neurological disability in both adults and children. The term "encephalitis" literally means inflammation of part or all of the "brain" or the brain parenchyma. Encephalitis affects people of all ages; however, the incidence is higher in the pediatric population. Although both genders are affected, most studies showed slight dominance in men. There are two main types with different causes: primary or infectious encephalitis can develop when a fungus, virus, or bacteria infects the brain and accounts for approximately 70% of confirmed cases of encephalitis, and secondary or post-infectious encephalitis when the immune system is active and reacts. to a previous infection and mistakenly attacks the brain. The clinical manifestations depend on whether the brain parenchyma or the meninges are predominantly involved and cause an encephalitic or meningitis syndrome. Diagnostic tests should include a lumbar puncture, an MRI of the brain, and an EEG for suspected  encephalitis. In encephalitis, a broad differential diagnosis, both infectious and non-infectious, should be considered. These alternatives include malignancy, autoimmune or paraneoplastic diseases (eg, anti-NMDA receptor encephalitis), brain abscess, drug-induced tuberculosis or delirium, neurosyphilis, or bacterial, fungal, protozoal, or helminthic encephalitis. Antiviral medications, such as intravenous acyclovir, are often given at the initial diagnosis of encephalitis before the cause is known. Acyclovir is the best treatment for herpes simplex encephalitis. If medication can be started soon after symptoms appear, the chance of a full recovery is much higher.

Keywords: Disability, encephalitis, inflammation, management, neurologic, brain parenchyma


How to Cite

Ajwah, Ibrahim Mahmoud H., Samirah Nawaf Naif Alrashidi, Nouf Zayed Omer Al mutairi, Ahmad Mazroa Almazroa, Abdulrahman Jaser F. Almutairi, Bushra Saad Alsakran, Mujeb Mosfer Mujeb Alzhrani, et al. 2021. “Prevalence, Causes and Management of Encephalitis”. Journal of Pharmaceutical Research International 33 (50A):312-18. https://doi.org/10.9734/jpri/2021/v33i50A33414.

Downloads

Download data is not yet available.